Anti-inflammatory drugs

Abstract

The purpose of the present invention is to provide a novel inflammation-suppressing agent. Provided are: an inflammation-suppressing agent containing a wavelength conversion substance as an active ingredient; a composition and a product each containing the inflammation-suppressing agent; and a method for suppressing an inflammation in the skin using the inflammation-suppressing agent, the composition or the product. According to the present invention, an inflammation can be suppressed in a dermal cell by effectively utilizing ultraviolet ray, whereby a desirable effect can be exerted on the skin.

Claims

1. A light-emitting inflammatory agent that contains a wavelength-converting substance as an active ingredient, The wavelength-converting material converts the wavelength of ultraviolet light contained in the incident light and emits light with a wavelength longer than the wavelength of the ultraviolet light. The aforementioned wavelength-converting substance is a zinc oxide phosphor, an anti-inflammatory agent.

2. Applying the anti-inflammatory agent described in claim 1 to the target skin; and This includes exposing the skin to light containing ultraviolet light after applying the aforementioned anti-inflammatory agent; A cosmetic method (excluding medical procedures) for suppressing inflammation in the target skin.

3. Allowing light containing ultraviolet light to pass through the anti-inflammatory agent according to claim 1; and Including exposing the target skin to the aforementioned transmitted light; A cosmetic method (excluding medical procedures) for suppressing inflammation in the target skin.

Images